CARTAKEBACK.COM LIMITED
Company number 04500288 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: CARTAKEBACK.COM LIMITED
1. Financial Health Score: B+ The patient exhibits a strong constitutional financial baseline with robust equity and consistent profitability. However, the score is held back from an 'A' due to recent "inflammation" in the working capital cycle—specifically, a significant swelling in trade debtors and trade creditors, which suggests the business is experiencing growing pains or cash flow bottlenecks that require monitoring.
2. Key Vital Signs
- Net Assets (Financial Bone Density): £1,067,700 The company’s net assets have grown to £1.07m, up from £896k in 2024. This indicates a very healthy structural foundation. The business is building retained earnings rather than leaking value.
- Profit Metabolism (P&L Reserve Growth): +£171,594 The Profit and Loss reserve grew from £496,106 to £667,700. Assuming no dividends were paid out, this represents the retained profit for the 2025 year. The business has a healthy metabolism, effectively converting its scrap car recycling and compliance services into bottom-line equity.
- Current Ratio (Liquidity Pulse): 1.81 With Current Assets of £1.08m against Current Liabilities of £598k, the company has a current ratio of roughly 1.81. This is a healthy pulse—meaning for every £1 of short-term debt, the company has £1.81 in short-term assets to cover it.
- Cash Reserves (Hydration Levels): £356,690 Cash has recovered to £356k, up significantly from the £200k low in 2024. While this is a positive recovery, it remains notably lower than the peak hydration years of 2018-2021 (where cash hovered between £476k-£763k).
- Trade Debtors (Arterial Flow): £717,025 This is the most concerning vital sign. Trade debtors have surged by 56% from £459k in 2024 to £717k in 2025. This suggests money is not flowing through the arteries to the heart (cash) as quickly as it should be.
3. Diagnosis
Overall Condition: Healthy but experiencing working capital strain.
The financial data reveals a business that is fundamentally sound but suffering from "circulatory congestion." The patient (the business) is generating strong revenues and profits, as evidenced by the growing P&L reserves and overall net assets. However, there is a noticeable blockage in the cash conversion cycle.
The swelling in Trade Debtors (£717k) suggests that the company is doing more work or issuing more invoices, but clients are taking longer to pay. Concurrently, Trade Creditors have almost doubled from £197k to £349k, indicating that the company is stretching out its own payments to suppliers to compensate for the slow incoming cash.
This dynamic explains why the cash reserves, while recovering, haven't returned to the lofty heights of previous years—the cash is trapped in the receivables pipeline. The £570k tied up in international subsidiary investments (Australia, New Zealand, and Ireland) also represents a substantial portion of capital that is currently locked away and illiquid.
4. Recommendations
To restore optimal financial wellness and prevent the current working capital strain from developing into a cash flow crisis, the following treatments are prescribed:
- Apply Pressure to Debtors (Credit Control): Implement stricter credit control procedures. The 56% spike in trade debtors requires immediate attention. Follow up on overdue invoices, consider offering early payment discounts, or tighten credit terms for new customers to clear the arterial blockage.
- Monitor Creditor Health: While stretching supplier payments (Trade Creditors up to £349k) is a natural reflex when cash is tight, be careful not to strain relationships with critical ATF partners or software providers to the point where service is disrupted.
- Check International Subsidiates: The £570,024 locked in group undertakings represents a significant portion of the balance sheet. Conduct a health check on the Australian, New Zealand, and Irish operations. If they are now self-sustaining, consider whether it is time to extract value (via dividends or loan repayments) to boost the UK parent's cash hydration.
- Maintain the Profit Diet: The core business model is clearly working, with strong profit generation. Continue focusing on the high-margin compliance services and manufacturer contributions, which serve as the healthy diet fueling the P&L reserve growth.